The expression of saporin, a ribosome-inactivating protein from the plant Saponaria officinalis, in Escherichia coli.

We have isolated and sequenced genomic clones from the DNA of Saponaria officinalis using a cDNA probe that encodes proteins with high homology to saporin-6, one of the most potent of the ribosome-inactivating proteins that is currently used for the construction of immunotoxins and mitotoxins. Sequence differences in the clones suggest a multigene family of proteins. These data agree with observations of several different proteins with ribosome-inactivating protein activity and similar structure. Two of the genomic clones encode proteins that have identical sequences to two of the four isoforms of saporin-6. We have inserted the DNA from one genomic clone into an Escherichia coli expression system that encodes a signal sequence for export to the bacterial periplasmic space. Exportation is observed and the isolated gene product has ribosome-inactivation activity similar to the native protein. Sequence analysis shows differential processing of the remaining plant signal sequence. The majority of the expressed protein remains intracellular and this material also shows high specific activity and differential processing. Saporin as an immunotoxin in clinical trial and as a mitotoxin in experimental models has been extremely efficacious. These data indicate the ability to produce fusion proteins with saporin and cell-binding ligands for production of new reagents for further clinical and experimental use.

• Publication year

  1993

• Venue

  Journal of Biological Chemistry

• Publication date

  1993-03-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0021-9258(18)53284-1PMID 8454624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-terminal sequence of some ribosome-inactivating proteins.

  2009cited by this paper
• Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease.

  1992cited by this paper
• Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.

  1992cited by this paper
• Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation

  1992cited by this paper
• Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin.

  1992cited by this paper
• Ribosome–Inactivating Proteins from Plants: Present Status and Future Prospects

  1992cited by this paper
• Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.

  1992cited by this paper
• A Saporin‐6 cDNA containing a precursor sequence coding for a carboxyl‐terminal extension

  1991cited by this paper
• Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor.

  1991cited by this paper
• Assessment of sequence features in internal regions of proteins

  1991cited by this paper
• DNA sequence of Mirabilis antiviral protein (MAP), a ribosome-inactivating protein with an antiviral property, from mirabilis jalapa L. and its expression in Escherichia coli.

  1991cited by this paper
• Cloning of trichosanthin cDNA and its expression in Escherichia coli.

  1991cited by this paper
• Single‐chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA

  1991cited by this paper
• Recombinant toxins for cancer treatment.

  1991cited by this paper
• Characteristics and performance of a bispecific F (ab'gamma)2 antibody for delivering saporin to a CD7+ human acute T-cell leukaemia cell line.

  1991cited by this paper
• Isolation and DNA sequence of a gene encoding alpha-trichosanthin, a type I ribosome-inactivating protein.

  1990cited by this paper
• Synthesis of saporin gene probes from partial protein sequence data Use of inosine-oligonucleotides, genomic DNA and the polymerase chain reaction

  1990cited by this paper
• Role of arginine 180 and glutamic acid 177 of ricin toxin A chain in enzymatic inactivation of ribosomes

  1990cited by this paper
• Expression and secretion of Mirabilis antiviral protein in Escherichia coli and its inhibition of in vitro eukaryotic and prokaryotic protein synthesis.

  1990cited by this paper
• Molecular cloning: A laboratory manual

  1990cited by this paper
• Nucleotide sequence of cDNA coding for saporin-6, a type-1 ribosome-inactivating protein from Saponaria officinalis.

  1989cited by this paper
• Pseudomonas exotoxin: chimeric toxins.

  1989cited by this paper
• Recombinant proricin binds galactose but does not depurinate 28 S ribosomal RNA

  1989cited by this paper
• Modification of ribosomal RNA by ribosome-inactivating proteins from plants.

  1988cited by this paper
• Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates.

  1988cited by this paper
• The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: the RNA N-glycosidase activity of the proteins.

  1988cited by this paper
• Expression of soluble and fully functional ricin A chain in Escherichia coli is temperature-sensitive.

  1988cited by this paper
• Ribosome‐inhibiting proteins, retroviral reverse transcriptases, and RNase H share common structural elements

  1988cited by this paper
• DNA methylation and tissue-specific transcription of the storage protein genes of maize

  1988cited by this paper
• The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA.

  1988cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantation.

  1988cited by this paper
• The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.

  1987cited by this paper
• Crystallization of ricin A chain obtained from a cloned gene expressed in Escherichia coli.

  1987cited by this paper
• Expression and secretion of foreign proteins in Escherichia coli.

  1987cited by this paper
• Characterization of a Saponaria officinalis seed ribosome-inactivating protein: immunoreactivity and sequence homologies.

  1985cited by this paper
• An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.

  1985cited by this paper
• Nucleotide sequence of cloned cDNA coding for preproricin.

  1985cited by this paper
• Characterization of translational inhibitors from Phytolacca americana. Amino-terminal sequence determination and antibody-inhibitor conjugates.

  1984cited by this paper
• Polypeptide microsequence analysis with the commercially available gas-phase sequencer.

  1984cited by this paper
• Secretion cloning vectors in Escherichia coli.

  1984cited by this paper
• Seasonal variations in different forms of pokeweed antiviral protein, a potent inactivator of ribosomes.

  1983cited by this paper
• Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree).

  1983cited by this paper
• DNA sequence of the gene for the outer membrane lipoprotein of E. coli: an extremely AT-rich promoter.

  1979cited by this paper

• A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma.

  2026cites this paper
• Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes

  2023influential citation
• Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience

  2022cites this paper
• A tumor microenvironment (TME)-responsive nanoplatform for systemic saporin delivery and effective breast cancer therapy.

  2021cites this paper
• Hosts for Hostile Protein Production: The Challenge of Recombinant Immunotoxin Expression

  2019cites this paper
• Astroglia in Alzheimer's Disease.

  2019cites this paper
• Nutraceuticals derived from seed storage proteins: Implications for health wellness

  2019cites this paper
• Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins

  2018cites this paper
• Noradrenergic Hypothesis Linking Neurodegeneration-Based Cognitive Decline and Astroglia

  2018cites this paper
• Purification and functional characterization of recombinant balsamin, a ribosome-inactivating protein from Momordica balsamina.

  2018cites this paper
• Substance P-saporin for the treatment of intractable pain

  2017cites this paper
• Hippocampal noradrenaline regulates spatial working memory in the rat

  2017cites this paper
• Functional characterization of a novel ribosome inactivating protein from Momordica balsamina

  2016cites this paper
• Individual Differences in Acute Pain-induced Endogenous Analgesia Predict Time to Resolution of Postoperative Pain in the Rat

  2015cites this paper
• Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.

  2015cites this paper
• Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat.

  2014cites this paper
• Current Status and Biomedical Applications of Ribosome-Inactivating Proteins

  2013cites this paper
• Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide.

  2013cites this paper
• Alpha-momorcharin: a ribosome-inactivating protein from Momordica charantia, possessing DNA cleavage properties.

  2013cites this paper
• Differential expression of saporin genes upon wounding, ABA treatment and leaf development.

  2010cites this paper
• Engineering a switchable toxin: the potential use of PDZ domains in the expression, targeting and activation of modified saporin variants.

  2010cites this paper
• Selective lesion of the developing central noradrenergic system: short‐ and long‐term effects and reinnervation by noradrenergic‐rich tissue grafts

  2010cites this paper
• Type I Ribosome-Inactivating Proteins from Saponaria officinalis

  2010cites this paper
• Noradrenergic neurons in the locus coeruleus contribute to neuropathic pain.

  2009cites this paper
• Molecularly imprinted polymers for proteome analysis.

  2008cites this paper
• Elucidation of feeding-related neuronal networks involved in the regulation of the hypophysiotropic thyrotropin-releasing hormone- and corticotropin- releasing hormone-synthesizing neurons in the rat

  2008cites this paper
• Expression and purification of cysteine introduced recombinant saporin.

  2008cites this paper
• Novel antibodies as anticancer agents

  2007cites this paper
• Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties

  2006cites this paper
• N‐terminal deletion affects catalytic activity of saporin toxin

  2006influential citation
• Chemical Dissection of Brain Glucoregulatory Circuitry

  2005cites this paper
• Involvement of brainstem catecholaminergic inputs to the hypothalamic paraventricular nucleus in estrogen receptor alpha expression in this nucleus during different stress conditions in female rats.

  2004cites this paper
• Cytotoxicity of ribosome‐inactivating protein saporin is not mediated through α2‐macroglobulin receptor

  2003cites this paper
• Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion.

  2003cites this paper
• Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation

  2001cites this paper
• The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome

  2000cites this paper
• The Immunolesioned Animal as a Model of Transmitter Dysfunction

  2000cites this paper
• Purification, crystallisation and preliminary X-ray diffraction study of ribosome inactivating protein: saporin.

  1999cites this paper
• In vitro production of dianthin from crown gall lines of carnation (Dianthus caryophyllus L.)

  1999cites this paper
• Targeted Delivery of DNA Encoding Cytotoxic Proteins through High-Affinity Fibroblast Growth Factor Receptors

  1998cites this paper
• Fusion of phospholipid vesicles induced by the ribosome inactivating protein saporin

  1997cites this paper
• The amino‐terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated

  1997cites this paper
• Fluorescence spectroscopic study of the interaction of saporin with phospholipid vesicles.

  1997cites this paper
• Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly(A).

  1997cites this paper
• Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica.

  1997cites this paper
• Characterization of a saporin isoform with lower ribosome-inhibiting activity.

  1997cites this paper
• Aggregation of phospholipid vesicles induced by the ribosome inactivating protein saporin.

  1996cites this paper
• Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings.

  1996cites this paper
• Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin.

  1995cites this paper
• Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.

  1994cites this paper
• Striatal patch compartment lesions reduce cocaine-induced repetitive behaviors

  year unknowncites this paper